Failed a Drug Test? How to Explain, Dispute or Retest

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026

Quick answer: A positive result isn't automatically final: prescription verification, confirmation -testing review and split-specimen retests resolve a meaningful share of disputed screens every year.

Invoke the MRO immediately

Federally regulated positives trigger a MRO interview — answer the call (three attempts over 24h) and declare EVERY prescription, OTC sleep aid, poppy-bagel lunch or hemp product honestly. Documented explanations convert positives to verified negatives legitimately.

Split-specimen retest rights

Federal programs store a second sealed vial exactly for disputes: request it within 60 days and any SAMHSA-certified lab re-runs confirmation. Employers in non-regulated states often honor parallel policies if asked in writing.

What NOT to do

Don't claim rare medical conditions without documentation; MROs verify with physicians. Don't admit use hoping sympathy helps — verification runs on evidence, and admissions close dispute doors permanently.

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)